Korea S.E.
06:00:00 2024-04-28 pm EDT
5-day change
1st Jan Change
7,450
KRW
+1.36%
+2.05%
+35.45%
DuChemBIO Co.,Ltd. announced that it has received KRW 5.37897425 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co.,Ltd., Korea Development Bank, Investment Arm, Komelon Corporation
On April 26, 2019, DuChemBIO Co.,Ltd. (XKON:A176750) closed the transaction.
Telix Pharmaceuticals Limited Enters into A Commercialisation and Partnership Agreement with Duchembio Co, Ltd
20-12-02
CI
Radiopharmaceutical Business Division of CareCamp Inc. agreed to acquire DuChemBIO Co.,Ltd. from Kim Jong-woo and others, in a reverse merger transaction for approximately KRW 210 billion.
20-11-23
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 4.5 billion in funding from RNR Partners Group Co., Ltd., YNK Company Inc.
20-09-28
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 4.5 billion in funding from RNR Partners Group Co., Ltd., YNK Company Inc.
20-09-22
CI
ITM Isotopen Technologien München and DuChemBio Sign Exclusive Licensing & Development Agreement for Solucin® TRT in South Korea
19-09-02
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 5.37897425 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co.,Ltd., Korea Development Bank, Investment Arm, Komelon Corporation
19-04-25
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 5.37897425 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co.,Ltd., Korea Development Bank, Investment Arm, Komelon Corporation
19-04-17
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 2.99996 billion in funding
18-12-18
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 2.99996 billion in funding
18-12-10
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 999.994 million in funding from Korea Investment & Securities Co., Ltd., Investment Arm
18-10-01
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 999.994 million in funding from Korea Investment & Securities Co., Ltd., Investment Arm
18-09-18
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 1.299994 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm
18-08-20
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 1.299994 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm
18-08-12
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 3 billion in funding
18-07-12
CI
DuChemBIO Co.,Ltd. announced that it expects to receive KRW 3 billion in funding
18-07-04
CI
DuChemBIO Co.,Ltd. announced that it has received KRW 2 billion in funding from Asam Asset Management Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm
18-03-11
CI
DuChemBio Co., Ltd. announced that it has received KRW 3 billion in funding.
15-07-27
CI
DuChemBio Co., Ltd. announced that it expects to receive KRW 3 billion in funding.
15-07-26
CI
DuChemBio Co., Ltd. announced that it has received KRW 2 billion in funding from Mega Investment Co., Ltd., ASAM Investment Advisory Company Limited.
15-03-17
CI
Duchem Bio Co., Ltd. announced that it expects to receive KRW 2 billion in funding from Mega Investment Co., Ltd., ASAM Investment Advisory Company Limited, and another investor.
15-03-11
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
DuChemBio Co Ltd is a Korea-based company principally engaged in the manufacture and sale of radiopharmaceuticals. The Company is engaged in the manufacture and sale of diagnostic radiopharmaceuticals such as radiopharmaceuticals for the diagnosis of Parkinson's disease, radiopharmaceuticals for the diagnosis of Alzheimer's disease, and radiopharmaceuticals for the diagnosis of brain tumors. In addition, the Company is engaged in the sale of computed tomography (CT) contrast agents and other products.
More about the company
1st Jan change
Capi.
+35.45% 146M +26.47% 664B +26.20% 567B -6.33% 354B +19.35% 330B +4.23% 286B +12.77% 234B +4.90% 199B -9.94% 196B -4.04% 148B
Other Pharmaceuticals
Stock Market Equities A176750 Stock
News DuChemBIO Co.,Ltd. DuChemBIO Co.,Ltd. announced that it has received KRW 5.37897425 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co.,Ltd., Korea Development Bank, Investment Arm, Komelon Corporation
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
DUCHEMBIO CO.,LTD. 
